ATG4B and diabetic kidney disease: Compared with the DM control group, VPS37A and ATG4B were significantly down-regulated with DKD progression, with FCs of 0.140 and 0.088 in advanced DKD, but 0.533 and 0.192 in early DKD, respectively (both p<0.01).